Los Angeles Capital Management
IOVA icon

Los Angeles Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History

Los Angeles Capital Management’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$180K Sell
43,186
-135,973
-76% -$517K ﹤0.01% 1198
2026
Q1 		$629K Buy
179,159
+59,299
+49% +$190K ﹤0.01% 800
2025
Q4 		$234K Buy
119,860
+94,989
+382% +$220K ﹤0.01% 1185
2025
Q3 		$54K Sell
24,871
-12,784
-34% -$30.2K ﹤0.01% 1338
2025
Q2 		$64.8K Buy
37,655
+21,101
+127% +$52.5K ﹤0.01% 1285
2025
Q1 		$55.1K Sell
16,554
-45,205
-73% -$233K ﹤0.01% 1073
2024
Q4 		$457K Hold
61,759
– – ﹤0.01% 832
2024
Q3 		$580K Buy
61,759
+37,635
+156% +$357K ﹤0.01% 823
2024
Q2 		$193K Buy
+24,124
New +$259K ﹤0.01% 1132
2020
Q4 		– Sell
-7,335
Closed -$241K – 1528
2020
Q3 		$241K Sell
7,335
-20,766
-74% -$637K ﹤0.01% 1338
2020
Q2 		$771K Buy
28,101
+5,855
+26% +$192K ﹤0.01% 947
2020
Q1 		$666K Sell
22,246
-2,695
-11% -$71.4K ﹤0.01% 817
2019
Q4 		$690K Hold
24,941
– – ﹤0.01% 931
2019
Q3 		$454K Sell
24,941
-23,389
-48% -$517K ﹤0.01% 1014
2019
Q2 		$1.19M Sell
48,330
-13,730
-22% -$207K 0.01% 790
2019
Q1 		$590K Buy
+62,060
New +$603K ﹤0.01% 1036

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Los Angeles Capital Management's IOVA Position: Q2 2026 in Review

Los Angeles Capital Management reduced its Iovance Biotherapeutics (IOVA) stake by 76% in Q2 2026, selling an estimated $517K and leaving 43,186 shares worth $180K. The position accounts for ﹤0.01% of the portfolio, ranked #1198.

Los Angeles Capital Management first reported a position in IOVA in Q1 2019 and has held it in 16 quarters since. The position peaked at $1.19M in Q2 2019. 293 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • Los Angeles Capital Management held 43,186 shares of Iovance Biotherapeutics worth $180K as of Q2 2026.
  • Los Angeles Capital Management sold 135,973 Iovance Biotherapeutics shares in Q2 2026, an estimated $517K.
  • Iovance Biotherapeutics made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #1198 holding.
  • Los Angeles Capital Management first reported a position in Iovance Biotherapeutics in Q1 2019 and has held it in 16 quarters since.
  • Los Angeles Capital Management's Iovance Biotherapeutics position peaked at $1.19M in Q2 2019.
  • 293 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.